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Purpose: Implant-based breast reconstruction has
multiple advantages such as decreased morbidity, shorter
operative time and faster recovery. However, postopera-
tive infection with tissue expander increases medical cost
and causes a delay in concurrent antineoplastic treatment.
To reduce tissue expander infection, it is important to
identify related risk factors and minimize them when
possible.
Methods:A retrospective review of patient records in a
single breast cancer center was performed. Eighty-six
tissue expanders were placed in 80 women for post-
mastectomy breast reconstruction. Variables including
patients’age, body mass index (BMI), preoperative breast
volume, operation time, drain indwelling time, postopera-
tive seroma/hematoma formation, chemotherapy, and
radiation therapy were evaluated. Infection was defined as
the status that shows any symptom of local inflammation
and identification of pathogens. Representative values
were compared through Student’s t-test and univariate and
multivariate analyses.
Results: We examined 86 postmastectomy tissue-
expanders which were placed between June 2004 and
April 2010. Seven cases of tissue expander infection
(8.1%) were identified. The infected tissue expander was
removed in three of the cases. The relationship between
BMI, and preoperative breast volume and that between
infection and non-infection groups were significant (p<
0.05). Univariate analysis showed significant association
between BMI (p=0.023) and preoperative breast volume
(p=0.037). Multivariate analysis revealed that BMI and
preoperative breast volume were independent variables
regarding tissue expander infection.
Conclusion: Certain characteristics of implant-based
breast reconstruction patients increase infection rate of
tissue expander. These risk factors should be monitored
and evaluated before surgeries for more successful out-
come.
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I. INTRODUCTION
A variety of reconstruction methods are currently
available. Amongst them, autologous reconstruction is
frequently recommended as it shows good postoperative
patient satisfaction, aesthetically superb results, and
greater endurance against antineoplstic therapy and
postoperative infection. However, the donor site should
be appropriately selected, and the patient’s general
condition should be considered, as the procedure might
accompany donor-site morbidity and complications.
Meanwhile, implant-based breast reconstruction is
preferred because of shorter operation time, lower donor
morbidity, and faster recovery compared to autologous
reconstruction, causing less physical and psychological
burden. In addition, newly developed diagnostic tools
and education for self-detection enable early diagnosis
of breast cancer. In particular, younger breast cancer
patients prefer methods that cause less donor-site dis-
ability and allow early recovery so that they can return
to their daily lives. Implant-based breast reconstruction
is in the spotlight as women are actively engaged in
economic and social activities.
1
While antibiotics and implants have been improved,
operational-site infection remains the most significant
problem. This incurs additional medical expenditures
and affects subsequent antineoplastic treatment. There-
fore, it is of great importance to identify the factors
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behind the risk of infection associated with implant-
based reconstruction surgery and to exercise caution
when treating patients during and after surgery.2
Thus, we investigated and evaluated individual risk
factors for tissue expander infection after mastectomy.
II. MATERIALS AND METHODS
We retrospectively reviewed records of 86 tissue
expanders implanted in 80 patients following mastectomy
at a single comprehensive breast cancer center between
June 2004 and April 2010. Prior to conducting this study,
the study was approved by the institutional review
board, and all patients granted informed consent for this
study. The patients’ information and their medical
histories were obtained through interviews during their
out-patient visits. Potential risk factors, including age,
body mass index (BMI), preoperative breast volume,
operation time, postoperative seroma and hematoma
formation, indwelling period of closed suction drain, and
history of chemotherapy and radiation therapy were
evaluated.
Each patient’s height and weight were measured at
admission to calculate BMI for operation. Operation time
was recorded from the start of reconstruction by the
plastic team to skin closure. All the other parameters
were collected from electronic medical records. All
operations were limited to the immediate reconstruction
following total mastectomy by a single breast oncologic
surgeon and reconstructive surgeon of the center.
Dissection of lymph nodes was planned in accordance
with preoperative staging work-up such as breast ultra-
sonography and MRI, and was decided based on the
tumor cells on the surgical margin, sentinel lymph node
and pathologic biopsy results. Tissue expanders were
placed after mastectomy, and their sizes were decided
based on the preoperative breast volume or the con-
tralateral breast volume. Augmentation or reduction of
the normal breast was considered and planned upon
patients’ request. In operations, the tissue expanders
were fully covered by the pectoralis major and serratus
anterior. Prophylactic antibiotics were administered for
all patients after operations. Tissue expansion was
carried out using sterile injectable saline from 18 days
after surgery depending on the patient’s progress. The
goals for tissue expansion were reached a minimum of
one month and a maximum of 12 months after initiating
the expansion. Expansion was discontinued when patients’
complained of discomfort or scheduled for concurrent
antineoplastic treatment.
In this study, infection was defined as operational site
erythema, local heating, complaints of tenderness,
purulent discharge from the operational wound site and
other clinical signs as well as pathogens identified in
patients’discharge. Elevated body temperature which
was either relieved or subsided after oral or intravenous
administration of antibiotics was also considered
infection.
To establish the risk factors of postoperative tissue
expander infection, patients without infection (non-
infection group) and with infection (infection group)
were compared, and the correlation between risk factors
and tissue expander infection was investigated. A
Student’s t-test and chi-square test were used to compare
the average values of the parameters between two groups,
and the correlation between risk factors and infection
after surgery was examined using univariate logistic
regression. Multivariate logistic regression was employed
to calculate the odds ratio and the contribution of the
risk factors that showed significant correlation in
univariate logistic regression analysis. In all statistical
analyses, values with p less than 0.05 were considered
significant.
III. RESULTS
A total of 86 tissue expanders of 80 patients, including
six patients with bilateral tissue expander insertion, were
analyzed. Tissue expander infection was identified in 7
cases (8.1%). Three of them were reported during the
expansion period. In 4 cases, infection was cured through
conservative management with antibiotics and non-
steroidal anti-inflammatory drugs. In the other 3 cases,
tissue expanders had to be removed.
The mean age of the patients was 42.5 years old. The
average age of the non-infection group was 40.2 years
and the infection group 47.1 years. The average BMI of
the non-infection group was 21.4 kg/m2 and the infection
group 23.8 kg/m2. The average preoperative breast
volume was 299 cc for the non-infection group and 401
cc for the infection-group. As such, the BMI and breast
volume showed significant differences between the two
groups (p < 0.05). The average operation time of non-
infection group was 2 hours and 23 minutes and infec-
tion group was 2 hours and 27 minutes, showing no
significant difference. The rate of immediate postopera-
tive seroma formation was 19% for the non-infection
group and 42.9% for the infection group (p > 0.05).
Hematoma was formed in 2.5% of the non-infection
group patients and 25% of the infection group patients
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(p> 0.05). A closed suction drain was placed in all patients
after operation, and the drain was kept inserted for a
mean period of 14.5 days for the non-infection group and
17 days for the infection group. Chemotherapy was
provided to 31 patients: 29 from the non-infection group
and 2 from the infection group. Radiation therapy was
given to only 6 non-infection patients (Table I).
In univariate logistic regression analysis, postoperative
tissue expander infection was correlated with BMI (p =
0.023) and with preoperative breast volume (p = 0.037).
Thus, BMI and preoperative breast volume were an-
alyzed in the multivariate model, and the analysis
identified BMI as an independent risk factor for tissue
expander infection after surgery. Infection incidents rose
by 1.47 times for each one kilogram per m2 of body mass
(p = 0.018). Infection incidents doubled for every 100 cc
of preoperative breast volume, which was not significant
(p = 0.065) (Tables II, III).
Wound culture was conducted using specimens taken
from discharge collected from five infection cases.
Pathogens were identified as methicillin-resistant S.
aureus in three cases, methicillin-sensitive S. aureus in
one, and diphtheroid in the other one. The three cases
with methicillin-resistant S. aureus were treated with
intravenous injection of vancomycin followed by surgical
drainage, tissue expanders had to be surgically removed
in all three cases.
IV. DISCUSSION
In our study, infection was observed in 7 cases (8.1%)
of the study population, which falls within the 3.5% to
24% infection range reported in previous studies.2-4 The
previous studies had different sizes of populations, and
their infection rates varied depending on the definition
of infection. This study used a broad definition of infec-
tion, including cases where pathogens were confirmed
through wound culture and all clinical signs such as
fever, complaint of pain at the surgical site, and visible
erythema. However, discomfort and pain expressed by
patients during the expansion process as well as fevers
related to chemotherapy were excluded from infection
criteria. Also excluded were the cases where only normal
flora of skin was confirmed by wound culture with no
clinical symptoms. The 3 infection cases identified during
expansion may be cases of retrograde infection via drain
tube or percutaneous infection through saline injection
procedure. Another possibility is that subclinical infec-
tion of expander which was contaminated at the time
of operation was exaggerated during expansion phase.
Since this is a retrospective study, the exact cause of
infections could not be explained, which is a limitation
of this study.
Considering the mean age of all patients, the mean
age of the infection group was relatively higher than the
non-infection group. However, there was no clear
correlation between tissue expander infection and age.
McCarthy and Pusic presented patient age as a possible
risk factor for complications after breast reconstruction
surgery. In their study with 153 patients, Antony and
Disa reported an increase in incidents of complications
after breast reconstruction operations in older patients.2,5
Nevertheless, Walton and Audisio found no clear cor-
relation between infection and age,6,7 and the same con-
Non-infection group (n=79) Infection group (n=7) p
Age (year)
Breast vol. (cc)
BMI (kg/m
2
)
Op. time (min)
Drain indwelling (days)
40.2
299
21.4
143
14.5
47.2
401
23.8
147
17
0.120
0.025*
0.008*
0.393
0.156
Seroma
Hematoma
CTx.
RTx.
19.0%
2.5%
38.0%
7.6%
42.9%
25%
28.6%
0%
0.203
0.105
0.703
0.884
Values for “Age”, “Breast vol.”, “BMI”, “Op. time”, “Drain indwelling” are mean values.
Values for “Seroma”, “Hematoma”, “CTx.”, “RTx.” are percentage of patients with experience.
*p<0.05.
Table I. Risk Factors of Tissue Expander Infection
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clusion was reached in this study.
BMIs of the non-infection and infection groups were
significantly different. The univariate logistic regression
analysis also confirmed a significant correlation between
tissue expander infection and BMI. A number of previous
studies also pointed out patients’ BMI as a risk factor
for postoperative complications. McCarthy and Pusic
examined 1,170 implant-based breast reconstructions and
found a high correlation between BMI and postoperative
infection and other complications. This correlation can
be explained in several ways. First, larger dissection
boundaries in obese patients mean greater exposure to
the external environment and subsequently more
pathogens. In addition, large skin flaps is associated with
Factor Total number Infection case p
Age (years) 0.117
55 77 5
55 < 9 2
Breast volume (cc) 0.037*
450 75 4
450 < 11 3
BMI (kg/m
2
) 0.023*
24 68 4
24 < 18 3
Operation time (min) 0.083
210 71 6
210 < 15 1
Drain maintain (days) 0.358
15 53 3
15 < 32 4
Seroma 0.409
Yes 18 3
No 68 4
Hematoma 0.118
Yes 4 2
No 82 5
CTx. 0.357
Yes 32 2
No 54 5
RTx. 0.999
Yes 6 0
No 80 7
*p<0.05
Table II. Univariate Analysis of Infection Risk Factor
Odds ratio p
BMI 1.47 per 1 unit increase 0.018*
Breast volume 2.00 per 100 cc increase 0.065
*p<0.05
Table III. Multivariate Analysis and Odds Ratio of
Tissue Expander Infection Risk Factors
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a higher rate of partial necrosis of mastectomy flaps,
causing higher chance of implants to infection. Obese
patients also tend to have poor general health conditions
and lower immunity, which could increase complications
after surgery.2,5,8
The correlation between preoperative breast volume
and infection was confirmed through univariate logistic
regression. This means that the bigger the preoperative
breast volume is, the greater the operational site and the
size of mastectomy flap are. This seems to contribute to
the increase contact surface with the expander and the
dead space, predisposing to infections. The same result
was obtained in other studies which examined the
correlations between complications, the weight of
excised breast tissue, and that of brassieres.
9,10 However,
in our study, we found no significant difference in the
operation time between the two groups. While breast size
tended to increase along with BMI, we separately
analyzed the correlation between infection and breast
size and that between infection and BMI.
After inserting the implant, the infection group
experienced a greater degree of postoperative seroma
and hematoma formation. Seroma and hematoma formed
at the operational site serve as a medium for micro-
organisms, leading to implant infection. Generally, a
closed suction drain is considered to prevent seroma and
hematoma formation. Nevertheless, in their cohort study
involving 1863 patients, McCarthy and Cordeiro con-
cluded that a closed suction drain did not prevent
formation of seroma and hematoma and complications
at surgical sites.11 In our study, we did not identify any
correlation between infection and an indwelling period
of the closed suction drain indwelling. Further study is
warranted to investigate whether placement of a closed
suction drain causes infection or whether a surgical site
infection prolongs the drain indwelling period.
The five cases of infection with purulent discharge
were identified during the outpatient follow up period.
Three of them where infection was caused by methicillin-
resistant S. aureus were treated by intravenous admini-
stration of vancomycin and salvage procedures of
surgical drainage, capsulectomy and tissue expander
irrigation. However, the implant had to be removed in
all three cases as infections persisted. In the other two
cases, no more signs of infection were observed after one
week of conservative treatment, including antibiotics
therapy, and tissue expansion was conducted as planned.
A 15-year study by Spear et al. also indicates a low
success rate of the salvage procedure in cases where
atypical pathogens, including methicillin-resistant S.
aureus. They used wound culture results as a basis for
the decision of whether the salvage procedure should
be performed or not.12
In our study, the infection and non-infection groups
exhibited no significant discrepancy in chemotherapy
and radiation therapy. Previous studies reported that
radiation treatment increases the rate of complication
such as infection and exposure of implants.9,13 At our
center, breast reconstruction is performed primarily in
patients at clinical stage II or earlier stages, most of
whom do not need chemotherapy. In addition, our breast
cancer treatment team employs chemotherapy rather
than radiation therapy for patients requiring antineo-
plastic treatment. As a result, the number of patients
treated with radiation therapy was insufficient to
compare their results with those treated with chemo-
therapy.
V. CONCLUSION
In this study, BMI and preoperative breast volume
showed a significant correlation with postoperative infec-
tion. For obese patients or patients with large breasts,
breast reconstruction methods should be carefully
selected, and close attention and special care are required
for postoperative wound management and prevention of
implant infection.
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